Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jenscare Scientific CoHKSE:09877 +0.60%33 EV-to-FCF is -28.97 as of Aug. 18, 2026. GuruFocus rates HKSE:09877 with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 405 Medical Devices & Instruments companies, Jenscare Scientific Co ranks worse than 246913.33% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Jenscare Scientific Co's Enterprise Value is HK$2,529.18 Mil.
Jenscare Scientific Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-87.31 Mil. Therefore, Jenscare Scientific Co's EV-to-FCF for today is -28.97.
The historical rank and industry rank for Jenscare Scientific Co's EV-to-FCF or its related term are showing as below:
HKSE:09877'
s EV-to-FCF Range Over the Past 10 Years
Min: -41.21 Med: -33.19 Max: -26.36
Current: -28.97
During the past 6 years, the highest EV-to-FCF of Jenscare Scientific Co was -26.36. The lowest was -41.21. And the median was -33.19.
HKSE:09877's EV-to-FCF is ranked worse than 100% of 405
companies
in the Medical Devices & Instruments industry
Industry Median: 24.79
vs HKSE:09877: -28.97
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Jenscare Scientific Co (HKSE:09877) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Jenscare Scientific Co's PE Ratio (TTM) for today is calculated as:
Jenscare Scientific Co's share price for today is HK$7.49.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jenscare Scientific Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.702.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Jenscare Scientific Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jenscare Scientific Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Jenscare Scientific Co's EV-to-FCF falls into.
Jenscare Scientific Co's current Enterprise Value is HK$2,529.18 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jenscare Scientific Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-87.31 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jenscare Scientific Co (HKSE:09877) has a EV-to-FCF of -28.97 as of Aug. 18, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Jenscare Scientific Co and its competitors. According to the industry distribution chart, Jenscare Scientific Co ranks #999999 out of 405 companies in the Medical Devices & Instruments industry.
Is Jenscare Scientific Co's EV-to-FCF too high?
Jenscare Scientific Co's current EV-to-FCF is -28.97. Based on the distribution chart, Jenscare Scientific Co ranks #999999 out of 405 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Jenscare Scientific Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Jenscare Scientific Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Jenscare Scientific Co ranks #999999 out of 405 companies for EV-to-FCF. This places Jenscare Scientific Co in the lower half of its industry. The industry median EV-to-FCF is 24.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.79, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Jenscare Scientific Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jenscare Scientific Co's current EV-to-FCF is -28.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jenscare Scientific Co stock overvalued right now?
Jenscare Scientific Co (HKSE:09877) has a current EV-to-FCF of -28.97. The current EV-to-FCF is -28.97. Jenscare Scientific Co's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Jenscare Scientific Co (HKSE:09877), the current EV-to-FCF is -28.97 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jenscare Scientific Co Ltd is engaged in the manufacturing, research, and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. Geographically, the company generates the majority of its revenue from the Chinese mainland.
33GF Score
Get the complete analysis for HKSE:09877
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09877 has been successfully added to your 
